首页 > 组织芯片 > 皮肤 > KIN481a
tissue microarray-KIN481a
  • 点数:
    48
    例数:
    22
    点样直径(mm):
    1.5
    厚度(µm):
    5
    行数:
    6
    列数:
    8
    组织阵列类型:
    FFPE
    种属:
    Human
KIN481a
加入收藏

描述: 多病理类型皮肤癌及边缘组织组合芯片,附病理分级、TNM和临床分期,22例/48点,替代SK481

详情: 多病理类型皮肤癌及边缘组织组合微阵列芯片,包含12例皮肤癌(6例鳞状细胞癌,6例基底细胞癌),12例边缘组织(其中2例与癌匹配),一块两点

应用: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • 说明书列表
  • 重复病例
  • 下载说明书
图表:
Skin
  • Malignant(*)
  • Malignant(I)
  • Malignant(II)
  • Malignant(III)
  • NAT(*)
  • _ki
组织芯片
KIN481a
1
2
3
4
5
6
7
8
A
Ski
Ski
Ski
Ski
Ski
Ski
Ski
Ski
B
Ski
Ski
Ski
Ski
Ski
Ski
Ski
Ski
C
Ski
Ski
Ski
Ski
Ski
Ski
Ski
Ski
D
Ski
Ski
Ski
Ski
Ski
Ski
Ski
Ski
E
Ski
Ski
Ski
Ski
Ski
Ski
Ski
Ski
F
Ski
Ski
Ski
Ski
Ski
Ski
Ski
Ski
_ki
KIN481a
  • 年龄:
  • 性别:
  • 器官/解剖部位:
  • 病理诊断:
  • 等级:
  • 分期:
  • 阶段:
  • 组织ID.:
  • 类型:
POS No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size Ki-67 CK5/6
A1
1 78 M Skin Squamous cell carcinoma of groin 2 T2N1M0 III Malignant * +,5% ++,100%
A2
2 78 M Skin Squamous cell carcinoma of groin 2 T2N1M0 III Malignant * +,10% ++,100%
A3
3 78 M Skin Adjacent normal tissue tissue * * * NAT * +,3% +++,100%
A4
4 78 M Skin Adjacent normal tissue tissue * * * NAT * +,3% +++,100%
A5
5 76 M Skin Squamous cell carcinoma of right armpit 2 T3N0M0 III Malignant 5*2 +,10% ++,100%
A6
6 76 M Skin Squamous cell carcinoma of right armpit 2 T3N0M0 III Malignant 5*2 +,15% ++,100%
A7
7 56 F Skin Adjacent normal tissue tissue * * * NAT * +,10% ++,100%
A8
8 57 F Skin Adjacent normal tissue tissue * * * NAT * +,3% ++,100%
B1
9 79 M Skin Squamous cell carcinoma of face 2 T2N0M0 II Malignant 5*3*1.5 ++,70% +++,100%
B2
10 79 M Skin Squamous cell carcinoma of face 2 T2N0M0 II Malignant 5*3*1.5 ++,70% +++,100%
B3
11 61 F Skin Adjacent normal tissue tissue * * * NAT * +,3% ++,80%
B4
12 61 F Skin Adjacent normal tissue tissue * * * NAT * +,3% ++,80%
B5
13 78 F Skin Squamous cell carcinoma of right temporal 1--2 T2N0M0 II Malignant * +,10% +++,100%
B6
14 78 F Skin Squamous cell carcinoma of right temporal 1--2 T2N0M0 II Malignant * +,10% +++,100%
B7
15 63 M Skin Adjacent normal tissue tissue * * * NAT * +,5% ++,60%
B8
16 63 M Skin Adjacent normal tissue tissue * * * NAT * +,10% ++,60%
C1
17 25 M Skin Squamous cell carcinoma of upper lip (sparse) 2--3 T2N0M0 II Malignant * ++,70% ++,100%
C2
18 25 M Skin Squamous cell carcinoma of upper lip 2--3 T2N0M0 II Malignant * ++,70% ++,100%
C3
19 63 M Skin Adjacent normal tissue tissue * * * NAT * +,3% ++,80%
C4
20 63 M Skin Adjacent normal tissue tissue * * * NAT * +,3% ++,80%
C5
21 87 F Skin Squamous cell carcinoma of pars zygomatica (interstitial) * * * Malignant 2*2*0.6 + *
C6
22 87 F Skin Squamous cell carcinoma of pars zygomatica 2 * * Malignant 2*2*0.6 +,35% +++,100%
C7
23 56 M Skin Adjacent normal tissue tissue * * * NAT * +,5% +,40%
C8
24 56 M Skin Adjacent normal tissue tissue * * * NAT * +,10% +,40%
D1
25 58 M Skin Basal cell carcinoma * T1N0M0 I Malignant 1.5*1.0*0.5 +,10% +++,100%
D2
26 58 M Skin Basal cell carcinoma * T1N0M0 I Malignant 1.5*1.0*0.5 +,10% +++,100%
D3
27 75 M Skin Adjacent normal tissue tissue * * * NAT * +,3% ++,100%
D4
28 75 M Skin Adjacent normal tissue tissue * * * NAT * +,3% ++,100%
D5
29 55 M Skin Basal cell carcinoma of head * T2N0M0 II Malignant * * +,30%
D6
30 55 M Skin Basal cell carcinoma of head * T2N0M0 II Malignant * * +,30%
D7
31 66 M Skin Adjacent normal tissue tissue * * * NAT * +,3% ++,100%
D8
32 66 M Skin Adjacent normal tissue tissue * * * NAT * +,8% ++,100%
E1
33 38 M Skin Basal cell carcinoma of right forehead * T1N0M0 I Malignant 2*1.5 +,15% ++,100%
E2
34 38 M Skin Basal cell carcinoma of right forehead (sparse) * T1N0M0 I Malignant 2*1.5 +,15% ++,100%
E3
35 66 M Skin Adjacent normal tissue tissue * * * NAT * +,3% +,30%
E4
36 66 M Skin Adjacent normal tissue tissue * * * NAT * +,3% +,30%
E5
37 61 M Skin Basal cell carcinoma of left face * T2N0M0 II Malignant 5*5 * +++,80%
E6
38 61 M Skin Basal cell carcinoma of left face * T2N0M0 II Malignant 5*5 +,3% +++,80%
E7
39 45 F Skin Adjacent normal tissue tissue * * * NAT * Basal cells,+,10% ++,60%
E8
40 45 F Skin Adjacent normal tissue tissue * * * NAT * Basal cells,+,10% ++,60%
F1
41 74 F Skin Basal cell carcinoma of right forehead * T2N0M0 II Malignant 3*3*2 * ++,100%
F2
42 74 F Skin Basal cell carcinoma of right forehead * T2N0M0 II Malignant 3*3*2 * ++,100%
F3
43 75 M Skin Adjacent normal tissue tissue * * * NAT * Basal cells,+,3% ++,60%
F4
44 75 M Skin Adjacent normal tissue tissue * * * NAT * Basal cells,+,3% ++,60%
F5
45 51 M Skin Basal cell carcinoma of scalp (sparse) * T3N0M0 III Malignant 5.0*4.0*2.0 +,15% +++,100%
F6
46 51 M Skin Basal cell carcinoma of scalp * T3N0M0 III Malignant 5.0*4.0*2.0 +,15% +++,100%
F7
47 51 M Skin Adjacent normal tissue tissue * * * NAT * Basal cells,+,10% ++,60%
F8
48 51 M Skin Adjacent normal tissue tissue * * * NAT * Basal cells,+,10% ++,60%
_kidney cancer_
查找与该芯片存在重复病例的芯片:
如需了解产品规格方面的任何问题,请联系我们
0.193092s